AA Edit | Covid: Time is not right to lower guard

As per the WHO, new infections are up 8% globally compared to the previous week, with 11 million new cases and over 43,000 new deaths

Russia seals deal to supply and test its coronavirus vaccine in India

Dr Reddy’s, one of India’s top pharmaceutical companies, will carry out Phase III clinical trials of Sputnik-V in India, RDIF said

The move came a day after the company stated that it would push ahead with the trials in India

"The government of India attaches great importance to this offer of partnership from a very special friend of this nation"

Rahul said that the Centre will need vaccine access strategy that is inclusive, ensuring availability, affordability and fair distribution

As of now, globally 141 vaccine candidates are being studied out of which 26 are in different stages of clinical trials

SII has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine COVISHIELD

Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India